Author:
Sinclair A M,Rogers N,Busse L,Archibeque I,Brown W,Kassner P D,Watson J E V,Arnold G E,Nguyen K C Q,Powers S,Elliott S
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K, Verma A (2001) Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res 61: 3561–3565
2. Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H, Verma A (2003) Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 162: 1789–1806
3. Berdel WE, Danhauser-Riedl S, Oberberg D, Zafferani M (1992) Effects of hematopoietic growth factors on malignant nonhematopoietic cells. Semin Oncol 19: 41–45
4. Berdel WE, Oberberg D, Reufi B, Thiel E (1991) Studies on the role of recombinant human erythropoietin in the growth regulation of human nonhematopoietic tumor cells in vitro. Ann Hematol 63: 5–8
5. Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, Trelle S, Weingart O, Bayliss S, Djulbegovic B, Bennett CL, Langensiepen S, Hyde C, Engert A (2006) Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 98: 708–714
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献